EUVIMEDAtklāt EUVIMED
ÜbersichtsarbeitSystematische ÜbersichtOpen access · CC BY 4.0

Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review

Sean Lim iD, Lucielle Standish, Harrison Liu, Eldho Paul, Weranja Ranasinghe

BJUI Compass · 2026-05 · 7 (5)

DOI: 10.1002/bco2.70201 ↗

At a glance

Übersichtsarbeit in BJUI Compass, published online on 2026-04-28. Written by Sean Lim and 4 co-authors. Institution: Department of Urology Monash Health Berwick Australia. 42 references. The full text is freely available (open access, CC BY 4.0).

AbstraktsSubjectsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

Background and objective Radical cystectomy (RC) is standard for muscle‐invasive disease (MIBC) and utilised frequently in high‐risk non‐muscle‐invasive bladder cancer (NMIBC). Pelvic lymph node dissection (PLND) is routinely performed during RC for MIBC, demonstrating a survival benefit. However, the oncologic value in NMIBC remains uncertain. As such, a systematic review was conducted to determine whether PLND confers an oncologic benefit in NMIBC patients undergoing RC. Materials and methods A systematic search of MEDLINE, Embase and PubMed (January 1989–January 2025) was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐analyses guidelines (CRD42023443011). Eligible studies included NMIBC patients undergoing RC with or without PLND. Data extraction and quality assessment (ROBINS‐I, MINORS) were performed independently by two reviewers.

Results

Twenty‐one retrospective studies ( n = 35 793) met inclusion criteria. Lymph node positivity ranged from 0% to 13%. Comparative studies consistently demonstrated improved overall survival and cancer‐specific survival with PLND, particularly among pT1 subgroups (pooled 5‐year OS = 71.8%, 95% CI 59.3–84.3). Several studies demonstrated a dose–response association between lymph node yield or dissection extent and improved outcomes. Benefits were inconsistent for Ta/Tis disease. Pathological upstaging occurred in 16%–36% of clinically staged cohorts. However, study quality was moderate, with heterogeneity in PLND definitions, staging methods and adjuvant treatment use.

Conclusions

PLND appears to improve staging and survival in high‐risk NMIBC, especially pT1 disease. Routine PLND for low‐risk Ta/Tis disease is unsupported. Standardised definitions of PLND extent and prospective evaluation are needed to confirm its therapeutic role.

Subjects

Author keywords

bladder cancercystectomylymph node dissectionnon‐muscle‐invasive bladder cancersurvival outcomessystematic review

Authors and institutions

  • Department of Urology Monash Health Berwick Australia.
  • Department of Medicine, Nursing & Health Sciences Monash University Berwick Australia.
  • Monash Centre for Health Research and Implementation Monash University Berwick Australia.

ORCID profiles: Sean Lim

Cite

APA

Lim, S., Standish, L., Liu, H., Paul, E., & Ranasinghe, W. (2026). Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review. BJUI Compass, 7(5). https://doi.org/10.1002/bco2.70201

Vancouver

Lim S, Standish L, Liu H, Paul E, Ranasinghe W. Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review. BJUI Compass. 2026;7(5). doi:10.1002/bco2.70201

BibTeX
@article{Lim2026,
  author = {Lim, Sean and Standish, Lucielle and Liu, Harrison and Paul, Eldho and Ranasinghe, Weranja},
  title = {Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review},
  journal = {BJUI Compass},
  year = {2026},
  volume = {7},
  number = {5},
  doi = {10.1002/bco2.70201}
}
Start for free →